Braveheart Bio, Attovia Join Growing Pipeline Of Biotech IPOs
Two venture-backed biotechnology firms filed plans for initial public offerings this week, both with plans to raise around $100 million for their public debut....To view the full article, register now.
Already a subscriber? Click here to view full article